Parameter | All patients | Non-sepsis | Sepsis |
---|---|---|---|
Number | 217 | 73 | 144 |
Sex (male/female) | 133/84 | 48/25 | 85/59 |
Age median (range) [years] | 64 (18–90) | 61 (18–85) | 65 (20–90) |
APACHE-II score median (range) | 18 (2–43) | 13.5 (2–33) | 19 (4–43) |
SOFA score median (range) | 9 (0–19) | 7.0 (0–17) | 9.5 (2–19) |
SAPS2 score median (range) | 41 (0–73) | 41.0 (13–72) | 40.5 (0–73) |
ICU days median (range) | 7 (1–137) | 6 (1–45) | 9 (1–137) |
Death during ICU n(%) | 46 (21.2%) | 9 (12.3%) | 37 (25.7%) |
Death overall (total) n(%) | 86 (39.6%) | 22 (30.1%) | 64 (44.4%) |
Mechanical ventilation n(%) | 144 (66.4%) | 46 (63%) | 98 (67%) |
Preexisting diabetes n(%) | 65 (30.0%) | 22 (30.1%) | 43 (29.9%) |
BMI median (range) [m2/kg] | 26.0 (15.3–86.5) | 25.7 (15.9–40.5) | 26.0 (15.3–86.5) |
WBC median (range) [×103/µl] | 12.9 (0.1–208) | 12.5 (1.8–29.6) | 13.8 (0.1–208) |
CRP median (range) [mg/dl] | 103.0 (5–230) | 17 (5–230) | 163.5 (5–230) |
IL-6 median (range) [pg/ml] | 145.0 (2–28,000) | 66.5 (1.5–5000) | 240 (2–28,000) |
Procalcitonin median (range) [pmol/l] | 0.7 (0.03–207.5) | 0.2 (0.03–100) | 1.8 (0.03–207.5) |
Creatinine median (range) [mg/dl] | 1.3 (0.1–15) | 1.0 (0.2–15) | 1.6 (0.1–10.7) |
INR median (range) | 1.16 (0.92–13) | 1.17 (0.95–6.73) | 1.16 (0.92–13) |
MR-proANP day 1 median (range) [pmol/l] | 214.0 (2.1–3417.0) | 147.2 (2.1–1625.0) | 246.6 (7.8–3417.0) |